Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomas. (Q48279348)
Jump to navigation
Jump to search
scientific article published on 22 November 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomas. |
scientific article published on 22 November 2012 |
Statements
1 reference
Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomas. (English)
1 reference
Michael Weller
1 reference
Wolfgang Wick
1 reference
Benedikt Wiestler
1 reference
Antje Wick
1 reference
Caroline Happold
1 reference
Katharina Seystahl
1 reference
Thomas Hundsberger
1 reference
22 November 2012
1 reference
1 reference
69
1 reference
2
1 reference
95-101
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference